Patents
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
06/2008
06/26/2008US20080152950 Anthracene derivative and organic electroluminescent device using the same
06/26/2008DE102006060598A1 New tetrahydrobenzoisoxazole compounds are mitotic motor protein Eg5 modulators useful to treat and prevent cancer, and to treat e.g. monocyte leukemia, glioblastoma, colon carcinoma, myelotic leukemia and lymphatic leukemia
06/25/2008EP1935892A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof
06/25/2008EP1935888A1 Method for sulfonating 1,2-benzisoxazole-3-acetic acid
06/25/2008EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
06/25/2008EP1935886A1 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
06/25/2008CN101208314A Benzisoxazole piperazine compounds and methods of use thereof
06/25/2008CN101208082A Niacin receptor agonists, compositions containing such compounds and methods of treatment
06/24/2008US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
06/24/2008US7390833 osteoarthritis; compounds inhibit Aggrecanase Activity of a disintegrin and metalloprotease with thrombosondin type I motifs; biaryl sulfonamid derivatives; N-({4'-[2-4-methylisoquinolin-3-yl)ethyl]-1,1 '-biphenyl-4-yl}sulfonyl)-D-valine
06/19/2008US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain.
06/19/2008US20080146624 Amidines as modulators of indoleamine 2,3-dioxygenase
06/19/2008US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof
06/19/2008US20080145356 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides
06/18/2008EP1932836A1 Isoxazoline-substituted benzamide compound and harmful organism-controlling agent
06/18/2008EP1931205A2 Transglutaminase inhibitors and methods of use thereof
06/18/2008CN101203498A Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
06/18/2008CN101200456A Bromine difluoro methyl substituted isoxazole derivatives
06/12/2008WO2007118323A8 Isoxazole derivatives as calcium channel blockers
06/12/2008WO2007110237A3 Amide derivatives and their application for the treatment of g protein related diseases
06/12/2008US20080139599 e.g. 4-[6-(5-methyl-2-phenyloxazol-4-ylmethoxy)-1-oxoindan-5-yl]benzoic acid; antidiabetic and antilipemic agent, obesity; atherosclerosis; coupling benzene derivatives folowed by hydration and alkylation
06/12/2008US20080139547 N-Hydroxyalkynylbenzamide (or hydroxamate) derivatives; anticarcinogenic and antiproliferative agents
06/12/2008US20080139390 Isoxazoline Derivatives and Their Use as Herbicides
06/10/2008US7385063 Method for preparing imidazole derivatives
06/10/2008US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof
06/10/2008CA2393995C Novel benzene sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
06/05/2008WO2008066131A1 Novel phenyl-isoxazol-3-ol derivative
06/05/2008US20080132706 Compounds as PDE IV and TNF Inhibitors
06/05/2008US20080132480 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
06/05/2008CA2668713A1 Novel phenyl-isoxazol-3-ol derivative
06/04/2008EP1343775B1 Piperazine derivatives
06/04/2008EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/04/2008EP1193250B1 Phenyl sulfamate derivatives
06/03/2008US7381687 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides
05/2008
05/29/2008WO2008062044A1 2-hydroxy-1,3-diaminopropane derivatives
05/29/2008US20080125470 N-(3-chloro-4-fluorophenyl)-N'-hydroxy-5-(2-(methylamino)-1,3-thiazol-4-yl)isoxazole-3-carboximidamide; cancer, viral infections, depression, a neurodegenerative disorder, trauma, age-related cataracts, organ transplant rejection, or an autoimmune disease
05/29/2008CA2669839A1 2-hydroxy-1,3-diaminopropane derivatives
05/28/2008EP1924569A2 Preparation of tetrahydro-1,8-dioxa-4a-aza-naphthalenes and their use in coating applications
05/28/2008EP1924554A1 Sulphonamide derivatives
05/27/2008US7378448 Diphenylether amide derivatives as opioid receptor antagonists
05/27/2008US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
05/22/2008WO2008060569A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
05/22/2008WO2008059023A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes
05/22/2008WO2008020007A3 Process for the preparation of 5-hydroxyisoxazolidines, 5-isoxazolidinones, b-amino acids, b-amino aldehydes and derivatives thereof
05/22/2008CA2669860A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes
05/22/2008CA2669596A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
05/21/2008EP1922311A2 Acyclic ikur inhibitors
05/21/2008EP1482924B1 Cathepsin cysteine protease inhibitors
05/21/2008EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
05/21/2008EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
05/21/2008CN101184739A Polycyclic oxadiazoles or isoxazoles and their use as S1P receptor ligands
05/21/2008CN100389110C Process of preparing aromatic ring substituted ixooxazoline compound
05/20/2008US7375233 Process for the preparation of zonisamide and the intermediates thereof
05/20/2008US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders
05/15/2008WO2008057775A2 Heterocyclic amide compounds useful as kinase inhibitors
05/15/2008WO2008057280A1 Multi-cyclic compounds and methods of use
05/15/2008US20080114167 Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners
05/15/2008US20080114044 Isoxazole compounds as Peroxisome Proliferator-Activated Receptor (PPAR) delta modulators; (5-{4-[2-(2,4-Dichloro-phenoxy)-ethyl-carbamoyl]-5-phenyl-isoxazol-3-yl}-phenyl)-acetic acid; diabetes, cardiovascular disorders, dyslipidemias, irritable bowel disease, cancer, skin disorders, eye disorders
05/15/2008US20080113997 Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
05/15/2008CA2672956A1 Calcium receptor modulating agents
05/14/2008EP1919882A2 Isoxazole combretastatin derivatives for the treatment of proliferative disorders
05/14/2008EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/13/2008US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl
05/13/2008US7371755 Antiviral agents
05/13/2008CA2235298C Isoxazole derivatives
05/08/2008WO2008053326A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
05/08/2008WO2008053325A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
05/08/2008US20080108679 Isoxazolic Derivative to Relieve Neuropathic Pain
05/08/2008US20080108668 compounds with biological activity against all sorts of plant diseases and insects at very low dosage, to control plant diseases like cucumber downy mildew, cucumber grey mold, cucumber powdery mildew, tomato early blight, tomato late blight, phytophthora blight of pepper, grape downy mildew and etc
05/08/2008US20080108601 anticancer agents; catalytic hydrogenation
05/08/2008US20080108595 Inhibitors of cathepsin s
05/08/2008CA2667515A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
05/08/2008CA2667513A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
05/07/2008EP1916896A2 Non-steroidal antiandrogens
05/07/2008EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
05/07/2008CN101172983A Substituted phenylacetic acids
05/06/2008US7368578 superior in an adipose tissue weight decreasing action and a retinoid-related receptor function regulating action; to treat obesity, diabetes mellitus, hyperlipidemia, impaired glucose tolerance, hypertension; fewer side effects; 4-{[2-(2-furyl)-1,3-oxazol-4-yl]methoxy}-3-methoxybenzaldehyde
05/06/2008US7368572 Anticancer agents
05/06/2008US7368473 Paclitaxel enhancer compounds
05/06/2008US7368224 Photopolymerizable composition
05/06/2008CA2430601C Piperazine derivatives
05/06/2008CA2377803C Phenyl sulfamate derivatives
05/02/2008WO2008050167A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
04/2008
04/30/2008CN100384418C Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
04/29/2008US7365088 Indazole-derivatives as factor Xa inhibitors
04/29/2008US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate
04/29/2008CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them
04/29/2008CA2363875C Method crystallising n-(4-trifluoromethylphenyl)-5-methyl-isoxazole-4-carboxamide
04/29/2008CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
04/24/2008WO2008011080A3 Benzo(d) isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine
04/24/2008US20080096943 Urea derivatives, for example, 1-(3,5-dimethyl-isoxazole-4-yl)-3-[4-[(4-fluorobenzyl)methylamino]-butyl]-urea; use in treating inflammatory or allergic condition such as an inflammatory or obstructive airways disease
04/24/2008US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/24/2008US20080096873 New compounds
04/22/2008US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid
04/17/2008WO2008044767A1 Aromatic amine derivative and use thereof
04/17/2008WO2008043263A1 Isoxazole derivatives and methods of treating diseases
04/17/2008WO2008024337A3 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
04/17/2008WO2008005528A3 Compositions and methods for the modulation of detrusor activity
04/17/2008US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease
04/17/2008US20080090840 Heterocyclic GPR40 Modulators
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 115